Amalgamated Bank Spring Works Therapeutics, Inc. Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 2,425 shares of SWTX stock, worth $90,937. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,425

Previous 2,425 -0.0%

Holding current value

$90,937

Previous $91,000 14.29%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$36.06 - $47.62 $4,868 - $6,428	135 Added 5.9%	2,425 $91,000
Q1 2024 Apr 23, 2024	SELL	$36.5 - $52.5 $269,224 - $387,240	-7,376 Reduced 76.31%	2,290 $113,000
Q4 2023 Feb 06, 2024	BUY	$18.94 - $37.24 $15,246 - $29,978	805 Added 9.08%	9,666 $353,000
Q3 2023 Nov 08, 2023	BUY	$23.12 - $31.38 $22,588 - $30,658	977 Added 12.39%	8,861 $205,000
Q2 2023 Aug 11, 2023	BUY	$23.15 - $32.71 $88,548 - $125,115	3,825 Added 94.24%	7,884 $206,000
Q1 2023 May 02, 2023	SELL	$24.97 - $34.05 $18,477 - $25,196	-740 Reduced 15.42%	4,059 $104,000
Q4 2022 Feb 10, 2023	BUY	$21.73 - $28.72 $3,759 - $4,968	173 Added 3.74%	4,799 $125,000
Q3 2022 Nov 09, 2022	BUY	$24.1 - $39.66 $385 - $634	16 Added 0.35%	4,626 $132,000
Q2 2022 Aug 15, 2022	SELL	$18.36 - $60.07 $2,772 - $9,070	-151 Reduced 3.17%	4,610 $113,000
Q1 2022 Jun 30, 2022	SELL	$48.97 - $65.46 $18,510 - $24,743	-378 Reduced 7.36%	4,761 $269,000
Q4 2021 Feb 15, 2022	SELL	$53.3 - $75.84 $3,997 - $5,688	-75 Reduced 1.44%	5,139 $319,000
Q3 2021 Oct 29, 2021	SELL	$62.66 - $88.26 $18,735 - $26,389	-299 Reduced 5.42%	5,214 $331,000
Q2 2021 Aug 16, 2021	BUY	$67.45 - $85.63 $142,994 - $181,535	2,120 Added 62.48%	5,513 $454,000
Q1 2021 May 13, 2021	SELL	$65.1 - $93.59 $22,133 - $31,820	-340 Reduced 9.11%	3,393 $250,000
Q4 2020 Feb 12, 2021	BUY	$48.36 - $77.92 $180,527 - $290,875	3,733 New	3,733 $270,000

Others Institutions Holding SWTX

# of Institutions

238

Shares Held

70M

Call Options Held

144K

Put Options Held

257K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.34B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Spring Works Therapeutics, Inc. Transaction History